Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

Background. Virologic failure (VF) on a first-line ritonavir-boosted protease inhibitor (PI/r) regimen is associated with low rates of resistance, but optimal management after failure is unknown. Methods. The analysis included participants in randomized trials who experienced VF on a first-line regi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zheng, Yu, Hughes, Michael D., Lockman, Shahin, Benson, Constance A., Hosseinipour, Mina C., Campbell, Thomas B., Gulick, Roy M., Daar, Eric S., Sax, Paul E., Riddler, Sharon A., Haubrich, Richard, Salata, Robert A., Currier, Judith S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155445/
https://ncbi.nlm.nih.gov/pubmed/24842909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados